Your browser doesn't support javascript.
loading
Safety and effectiveness of outpatient parenteral antimicrobial therapy in older people.
Mujal, Abel; Sola, Joan; Hernandez, Manuel; Villarino, Maria-Antonia; Baylina, Mireia; Tajan, Juan; Oristrell, Joaquim.
Afiliação
  • Mujal A; Home Hospital Unit, Department of Internal Medicine, Sabadell Hospital, Corporació Sanitària Parc Taulí, Universitat Autònoma de Barcelona, Parc Taulí s/n, Sabadell, Barcelona, 08208, Spain amujal@tauli.cat.
  • Sola J; Home Hospital Unit, Department of Internal Medicine, Sabadell Hospital, Corporació Sanitària Parc Taulí, Universitat Autònoma de Barcelona, Parc Taulí s/n, Sabadell, Barcelona, 08208, Spain.
  • Hernandez M; Home Hospital Unit, Department of Internal Medicine, Sabadell Hospital, Corporació Sanitària Parc Taulí, Universitat Autònoma de Barcelona, Parc Taulí s/n, Sabadell, Barcelona, 08208, Spain.
  • Villarino MA; Acute Geriatric Unit, Albada Centre Sociosanitari, Corporació Sanitària Parc Taulí, Universitat Autònoma de Barcelona, Parc Taulí s/n, Sabadell, Barcelona, 08208, Spain.
  • Baylina M; Department of Internal Medicine, Sabadell Hospital, Corporació Sanitària Parc Taulí, Universitat Autònoma de Barcelona, Parc Taulí s/n, Sabadell, Barcelona, 08208, Spain.
  • Tajan J; Department of Internal Medicine, Sabadell Hospital, Corporació Sanitària Parc Taulí, Universitat Autònoma de Barcelona, Parc Taulí s/n, Sabadell, Barcelona, 08208, Spain.
  • Oristrell J; Department of Internal Medicine, Sabadell Hospital, Corporació Sanitària Parc Taulí, Universitat Autònoma de Barcelona, Parc Taulí s/n, Sabadell, Barcelona, 08208, Spain.
J Antimicrob Chemother ; 71(5): 1402-7, 2016 May.
Article em En | MEDLINE | ID: mdl-26832749
ABSTRACT

OBJECTIVES:

We analyse the safety and effectiveness of self-outpatient parenteral antimicrobial therapy (s-OPAT) in older patients.

METHODS:

We prospectively evaluated all adults admitted to our home hospitalization unit (HHU) for s-OPAT in the period 2008-12 in whom the bacteria responsible for the infection were identified. We divided patients into three age groups <65, 65-79 and ≥80 years. s-OPAT was administered by patients or their caregivers using elastomeric infusion devices. Effectiveness was assessed by analysing readmissions to hospital for inadequate control of underlying infection. Safety was assessed by analysing adverse events, catheter-related complications and readmission to hospital for causes unrelated to inadequate control of underlying infection.

RESULTS:

During the study period, 420 episodes of s-OPAT were registered in 351 patients 139 (33.1%) in patients aged <65 years, 182 (43.3%) in those aged 65-79 years and 99 (23.6%) in those aged ≥80 years. Patients aged ≥80 years had a significantly lower Barthel index. The length of stay for s-OPAT and the complete HHU stay were similar in the three groups. Older people had similar changes in antibiotic treatment and hospital readmission rates due to poor control of underlying infection but higher readmission rates due to worsening of underlying diseases than younger adults. Adverse events and catheter-related complications were similar in the three age groups.

CONCLUSIONS:

s-OPAT administered by patients or their caregivers using elastomeric devices was safe and effective in the treatment of infections in older people.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Assistência Ambulatorial / Anti-Infecciosos Tipo de estudo: Observational_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Assistência Ambulatorial / Anti-Infecciosos Tipo de estudo: Observational_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha